Self-assembling peptide nanofiber HIV vaccine elicits robust vaccine-induced antibody functions and modulates Fc glycosylation.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
23 09 2022
Historique:
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 28 9 2022
Statut: ppublish

Résumé

To develop vaccines for certain key global pathogens such as HIV, it is crucial to elicit both neutralizing and non-neutralizing Fc-mediated effector antibody functions. Clinical evidence indicates that non-neutralizing antibody functions including antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) contribute to protection against several pathogens. In this study, we demonstrated that conjugation of HIV Envelope (Env) antigen gp120 to a self-assembling nanofiber material named Q11 induced antibodies with higher breadth and functionality when compared to soluble gp120. Immunization with Q11-conjugated gp120 vaccine (gp120-Q11) demonstrated higher tier 1 neutralization, ADCP, and ADCC as compared to soluble gp120. Moreover, Q11 conjugation altered the Fc N-glycosylation profile of antigen-specific antibodies, leading to a phenotype associated with increased ADCC in animals immunized with gp120-Q11. Thus, this nanomaterial vaccine strategy can enhance non-neutralizing antibody functions possibly through modulation of immunoglobulin G Fc N-glycosylation.

Identifiants

pubmed: 36149967
doi: 10.1126/sciadv.abq0273
pmc: PMC9506727
doi:

Substances chimiques

AIDS Vaccines 0
HIV Antibodies 0
Immunoglobulin Fc Fragments 0
Immunoglobulin G 0
Vaccines, Subunit 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabq0273

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI064518
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI145016
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007392
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008555
Pays : United States

Références

Nat Med. 2000 Feb;6(2):200-6
pubmed: 10655110
Science. 2021 Jun 4;372(6546):1102-1105
pubmed: 34083490
Science. 2019 Feb 8;363(6427):649-654
pubmed: 30573546
J Infect Dis. 2007 Nov 15;196 Suppl 2:S430-7
pubmed: 17940980
J Clin Invest. 2019 Sep 3;129(9):3492-3498
pubmed: 31478910
Cancer Res. 2010 Jun 1;70(11):4481-9
pubmed: 20484044
ACS Chem Biol. 2015 Aug 21;10(8):1817-24
pubmed: 25970017
Nat Nanotechnol. 2020 Aug;15(8):716-723
pubmed: 32601450
J Immunol. 1982 Jul;129(1):370-6
pubmed: 6282968
Nat Nanotechnol. 2021 Apr;16(4):1-14
pubmed: 32807876
Sci Transl Med. 2021 Jun 2;13(596):
pubmed: 33979301
Nat Protoc. 2013 Sep;8(9):1800-7
pubmed: 23989674
J Virol. 2014 Mar;88(6):3329-39
pubmed: 24390332
Sci Transl Med. 2015 Oct 21;7(310):310rv7
pubmed: 26491081
Sci Rep. 2021 Jul 14;11(1):14494
pubmed: 34262096
J Control Release. 2018 Jul 28;282:120-130
pubmed: 29673645
Sci Immunol. 2020 Jun 19;5(48):
pubmed: 32561559
Adv Healthc Mater. 2013 Aug;2(8):1114-9
pubmed: 23436779
Immunity. 2020 Sep 15;53(3):548-563.e8
pubmed: 32857950
J Virol. 2019 May 1;93(10):
pubmed: 30842326
Cytometry A. 2018 Apr;93(4):436-447
pubmed: 29498807
Sci Immunol. 2018 Aug 17;3(26):
pubmed: 30120121
N Engl J Med. 2021 Mar 25;384(12):1089-1100
pubmed: 33761206
Sci Transl Med. 2020 Nov 4;12(568):
pubmed: 33148624
J Infect Dis. 2012 Aug 1;206(3):431-41
pubmed: 22634875
ACS Nano. 2012 Feb 28;6(2):1557-64
pubmed: 22273009
J Immunol Methods. 2014 Jul;409:131-46
pubmed: 24291345
J Infect Dis. 2015 Feb 15;211(4):508-17
pubmed: 25170104
Nat Commun. 2017 Nov 23;8(1):1732
pubmed: 29170366
J Virol. 2013 May;87(10):5468-76
pubmed: 23468489
J Immunol Methods. 2011 Mar 7;366(1-2):8-19
pubmed: 21192942
J Virol. 1999 Nov;73(11):8966-74
pubmed: 10516002
Virology. 2010 Dec 5;408(1):1-13
pubmed: 20863545
Science. 2019 Dec 6;366(6470):
pubmed: 31806786
Nat Med. 2014 Feb;20(2):143-51
pubmed: 24412922
N Engl J Med. 2012 Apr 5;366(14):1275-86
pubmed: 22475592
Sci Immunol. 2021 Dec 03;6(66):eabf1152
pubmed: 34860581
Immunity. 2017 May 16;46(5):804-817.e7
pubmed: 28514687
Annu Rev Immunol. 2016 May 20;34:635-59
pubmed: 27168247
Nat Mater. 2014 Aug;13(8):829-36
pubmed: 24930032
J Virol. 2010 Feb;84(3):1302-13
pubmed: 19906907
Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):
pubmed: 33876753
Trends Immunol. 2017 May;38(5):358-372
pubmed: 28385520
Adv Healthc Mater. 2014 Nov;3(11):1898-908
pubmed: 24923735
Retrovirology. 2017 Dec 21;14(1):57
pubmed: 29268769
J Virol. 2001 Sep;75(17):8340-7
pubmed: 11483779
Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):622-7
pubmed: 20080728
Cytometry A. 2011 Aug;79(8):603-12
pubmed: 21735545
J Immunol Methods. 2013 Jan 31;387(1-2):21-35
pubmed: 23023090
Front Immunol. 2019 Nov 27;10:2741
pubmed: 31827470
N Engl J Med. 2009 Dec 3;361(23):2209-20
pubmed: 19843557
Science. 2021 Feb 26;371(6532):
pubmed: 33361116
J Immunol Methods. 2015 Feb;417:34-44
pubmed: 25523925
MAbs. 2018 Jul;10(5):693-711
pubmed: 29733746
J Biol Chem. 2003 Jan 31;278(5):3466-73
pubmed: 12427744
Stat Med. 2016 May 10;35(10):1706-21
pubmed: 26585756
J Clin Invest. 2013 May;123(5):2183-92
pubmed: 23563315
J Immunol Methods. 2014 Jul;409:99-106
pubmed: 24928650
Biomaterials. 2017 Dec;149:1-11
pubmed: 28982051
Cell Rep. 2017 Dec 26;21(13):3681-3690
pubmed: 29281818
PLoS Pathog. 2016 Aug 31;12(8):e1005817
pubmed: 27579713
N Engl J Med. 2021 Mar 18;384(11):1003-1014
pubmed: 33730454
J Biol Chem. 2002 Jul 26;277(30):26733-40
pubmed: 11986321
J Proteome Res. 2013 Mar 1;12(3):1223-34
pubmed: 23339644
Nat Rev Immunol. 2010 Nov;10(11):787-96
pubmed: 20948547
Nat Med. 2000 Feb;6(2):207-10
pubmed: 10655111
Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):3485-3490
pubmed: 28289219
Immunol Rev. 2020 Jul;296(1):120-131
pubmed: 32483855
Nat Immunol. 2021 Jan;22(1):67-73
pubmed: 33169014
Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):6267-6272
pubmed: 29712861
Retrovirology. 2015 Sep 26;12:82
pubmed: 26410741
Exp Mol Med. 2017 Mar 24;49(3):e305
pubmed: 28336958
Front Immunol. 2020 Aug 18;11:1855
pubmed: 32973764
J Allergy Clin Immunol. 2020 Sep;146(3):652-666.e11
pubmed: 32445838
Nature. 2013 Apr 25;496(7446):469-76
pubmed: 23552890
Science. 2017 Jan 27;355(6323):395-398
pubmed: 28126818
Biomaterials. 2013 Nov;34(34):8776-85
pubmed: 23953841
Nat Med. 2009 Aug;15(8):951-4
pubmed: 19525965

Auteurs

Jui-Lin Chen (JL)

Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.

Chelsea N Fries (CN)

Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.

Stella J Berendam (SJ)

Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.

Nicole S Rodgers (NS)

Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA.

Emily F Roe (EF)

Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.

Yaoying Wu (Y)

Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.

Shuk Hang Li (SH)

The Cell and Molecular Biology Graduate Group, University of Pennsylvania, Philadelphia, PA 19104, USA.

Rishabh Jain (R)

Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.

Brian Watts (B)

Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.

Joshua Eudailey (J)

Department of Pediatrics, Weill Cornell Medicine, New York, NY 10065, USA.

Richard Barfield (R)

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham NC 27710, USA.
Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC 27707, USA.

Cliburn Chan (C)

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham NC 27710, USA.
Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC 27707, USA.

M Anthony Moody (MA)

Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA.

Kevin O Saunders (KO)

Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA.

Justin Pollara (J)

Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA.

Sallie R Permar (SR)

Department of Pediatrics, Weill Cornell Medicine, New York, NY 10065, USA.

Joel H Collier (JH)

Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.

Genevieve G Fouda (GG)

Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH